The Research Center of Southern California, LLC — Carlsbad, California

The Research Center of Southern California, LLC is a clinical research site located in Carlsbad, California, United States 92011.

Crixeo Clinical Trials Trust Score: 14/100 (FAILING). This profile has not yet been claimed by the site owner.

The Research Center of Southern California, LLC has participated in 4 clinical trials.

Therapeutic areas: Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Migraine, With or Without Aura.

Sponsors: Genentech, Inc., Actelion, Allergan.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Carlsbad

Browse all research sites in California · View every site in Carlsbad

Sponsor Feasibility Report

Trust Score: 14/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The Research Center of Southern California, LLC?

The Research Center of Southern California, LLC has a Crixeo Trust Score of 14/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The Research Center of Southern California, LLC conducted?

The Research Center of Southern California, LLC has 4 clinical trials on record. Their work covers Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Migraine, With or Without Aura.

Is The Research Center of Southern California, LLC accredited by Crixeo Clinical Trials?

The Research Center of Southern California, LLC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The Research Center of Southern California, LLC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.